Literature DB >> 3005597

1,25-Dihydroxyvitamin D3 receptors identified in the rat heart.

M R Walters, D C Wicker, P C Riggle.   

Abstract

Specific receptors for 1,25-dihydroxyvitamin D3, the active hormonal form of vitamin D3, were demonstrated in low salt chromatin preparations from normal rat hearts. Sucrose gradient analysis of KCl-extracted chromatin yielded a significant (P less than 0.005) peak of specific [3H]1,25-dihydroxyvitamin D3 binding in the 3.6S region. The peak of [3H]1,25-dihydroxyvitamin D3 binding was abolished by excess 1,25-dihydroxyvitamin D3, but not by 50 nM 25-hydroxyvitamin D3 nor by 1.0 microM levels of estradiol-17B, cortisol, or promegestone, demonstrating steroid specificity characteristic for such receptors. Upon Scatchard analysis this putative cardiac 1,25-dihydroxyvitamin D3 receptor yielded a single binding component with high affinity (KD = 0.36 nM) and low capacity (Nmax = 33 fmol/g tissue). Coupled with evidence for the presence of calcium binding proteins in this tissue, these observations suggest functional roles for 1,25-dihydroxyvitamin D3 and its receptors in cardiac muscle, possibly in regulating intracellular effects of calcium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005597     DOI: 10.1016/s0022-2828(86)80983-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  25 in total

Review 1.  Vitamin D and the heart.

Authors:  David G Gardner; Songcang Chen; Denis J Glenn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

2.  1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.

Authors:  T Mitsuhashi; R C Morris; H E Ives
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Vitamin D status is not related to development of atrial fibrillation in the community.

Authors:  Michiel Rienstra; Susan Cheng; Martin G Larson; Elizabeth L McCabe; Sarah L Booth; Paul F Jacques; Steven A Lubitz; Xiaoyan Yin; Daniel Levy; Jared W Magnani; Patrick T Ellinor; Emelia J Benjamin; Thomas J Wang
Journal:  Am Heart J       Date:  2011-08-11       Impact factor: 4.749

4.  Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro.

Authors:  J Merke; W Hofmann; D Goldschmidt; E Ritz
Journal:  Calcif Tissue Int       Date:  1987-08       Impact factor: 4.333

Review 5.  Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralcorticoids, and soltriol [vitamin D] on central nervous regulatory and peripheral tissues.

Authors:  W E Stumpf
Journal:  Experientia       Date:  1990-01-15

6.  Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.

Authors:  Angela Yee-Moon Wang; Fang Fang; John Chan; Yue-Yi Wen; Shang Qing; Iris Hiu-Shuen Chan; Gladys Lo; Kar-Neng Lai; Wai-Kei Lo; Christopher Wai-Kei Lam; Cheuk-Man Yu
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

7.  Vitamin D status in neonates undergoing cardiac operations: relationship to cardiopulmonary bypass and association with outcomes.

Authors:  Eric M Graham; Sarah N Taylor; Sinai C Zyblewski; Bethany Wolf; Scott M Bradley; Bruce W Hollis; Francis X McGowan; Andrew M Atz
Journal:  J Pediatr       Date:  2012-11-10       Impact factor: 4.406

8.  Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity.

Authors:  Songcang Chen; Christopher S Law; David G Gardner
Journal:  J Steroid Biochem Mol Biol       Date:  2009-12-02       Impact factor: 4.292

Review 9.  Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood.

Authors:  Oksan Gezmish; Mary Jane Black
Journal:  J Cardiovasc Transl Res       Date:  2013-05-30       Impact factor: 4.132

10.  Vitamin D receptors in heart: effects on atrial natriuretic factor.

Authors:  H J Bidmon; J Gutkowska; R Murakami; W E Stumpf
Journal:  Experientia       Date:  1991-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.